# US 2024/0050281 A1 · Method for the manufacture of a wound care product, and wound care product

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0050281 A1
- Document ID: US20240050281A1
- Status: Published application
- Kind: A1
- Application number: 18/257,813
- Filed: 2021-12-14
- Published: 2024-02-15
- Earliest claimed: 2020-12-15
- Assignees: Lohmann & Rauscher GmbH & Co. KG
- Applicants: Lohmann & Rauscher GmbH
- Inventors: Tina Leeb; Milijana Roljic; Christopher Panhölzl; Stefanie Schipali; Wolfgang Harreither; Patricia Buchegger
- Web page: https://patentgrep.com/patent/US20240050281A1

## CPC

- A61F 13/00991: {for treating webs, e.g. for moisturising, coating, impregnating or applying powder}
- A01N 25/30: characterised by the surfactants
- A01N 47/44: Guanidine; Derivatives thereof
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A61F 13/00063: {comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00)}
- A61F 13/0206: with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
- A61F 13/0213: {the fluid retention member being a layer of hydrocolloid, gel forming material}
- A61F 13/0276: {Apparatus or processes for manufacturing adhesive dressings or bandages}
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/785: Polymers containing nitrogen
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 15/46: Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- C08L 1/286: {substituted with acid radicals, e.g. carboxymethyl cellulose [CMC] (C08L1/282 takes precedence)}
- A61F 2013/00229: {with alginate}
- A61F 2013/00523: {with hydrogel}
- A61F 2013/00676: {hydrogel}
- A61F 2013/00689: {water-based}
- A61F 2013/00748: {with hydrocolloids or superabsorbers}
- A61L 2300/206: Biguanides, e.g. chlorohexidine
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L 2300/802: Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

Method for the manufacture of a wound care product in which a fabric containing hydroactive constituents, in particular fibres, is processed, whereby the processing of the fabric comprises the application of an antimicrobial means onto the hydroactive constituents.

## Claims

### Claim 1

Method for the manufacture of a wound care product in which a fabric containing hydroactive constituents, in particular fibres, is processed, characterised in that the processing of the fabric comprises the application of an antimicrobial means onto the hydroactive constituents.

### Claim 2 (depends on 1)

Method according to claim 1, characterised in that the antimicrobial means is applied in a preferably aqueous solution.

### Claim 3 (depends on 2)

Method according to claim 2, characterised in that the solution containing the antimicrobial means is sprayed preferably onto both sides of the fabric, in particular with at least one ultrasonic nozzle.

### Claim 4 (depends on 2)

Method according to claim 2, characterised in that 10−4 mg or more, in particular 4*10−3 mg or more, of the antimicrobial means is applied per cm2 of a respective side of the fabric.

### Claim 5 (depends on 2)

Method according to claim 2, characterised in that 1.0 mg or less, in particular 0.7 mg or less, of the antimicrobially effective means is applied per cm2 of a respective side of the fabric.

### Claim 6 (depends on 1)

Method according to claim 1, characterised in that the antimicrobial means has PHMB.

### Claim 7 (depends on 6)

Method according to claim 6, characterised in that PHMB is present in an aqueous solution in a concentration in the range of 0.1 to 9% by weight, in particular in the range of 4 to 9% by weight, whereby preferably 0.1 to 8 mg, in particular 2 to 8 mg, of the solution is applied per cm2 to a respective side of the fabric.

### Claim 8 (depends on 1)

Method according to claim 1, characterised in that a chelator is applied to the hydroactive constituents.

### Claim 9 (depends on 8)

Method according to claim 8, characterised in that the chelator is applied in the preferably aqueous solution, in particular is sprayed on.

### Claim 10 (depends on 8)

Method according to claim 8, characterised in that 5*10−4 mg or more, in particular 10−2 mg or more, of the chelator is applied per cm2 of a respective side of the fabric.

### Claim 11 (depends on 8)

Method according to claim 8, characterised in that 1.2 mg or less, in particular 0.8 mg or less, of the chelator is applied per cm2 of a respective side of the fabric.

### Claim 12 (depends on 8)

Method according to claim 8, characterised in that the chelator has EDTA, in particular EDTA disodium salt.

### Claim 13 (depends on 12)

Method according to claim 12, characterised in that EDTA is present in the aqueous solution in a concentration in the range of 0.5 to 15% by weight, in particular in the range of 5 to 10.4% by weight, whereby preferably 0.1 to 8 mg, in particular 2 to 8 mg, of the solution is applied per cm2 to a respective side of the fabric.

### Claim 14 (depends on 1)

Method according to claim 1, characterised in that at least one tenside, such as EHG, and/or a polysorbate is applied to the hydroactive constituents.

### Claim 15 (depends on 14)

Method according to claim 14, characterised in that the tenside is applied in the preferably aqueous solution, in particular is sprayed on.

### Claim 16 (depends on 14)

Method according to claim 14, characterised in that 10−4 mg or more, in particular 5*10−4 mg or more, more preferably 10−3 mg or more, of the tenside is applied per cm2 of a respective side of the fabric.

### Claim 17 (depends on 14)

Method according to claim 14, characterised in that 0.6 mg or less, in particular 0.1 mg or less, of the tenside is applied per cm2 of a respective side of the fabric.

### Claim 18 (depends on 14)

Method according to claim 14, characterised in that the tenside is present in the aqueous solution in a concentration in the range of 0.1 to 7% by weight, in particular 0.1 to 5% by weight, whereby preferably 0.1 to 8 mg, in particular 2 to 8 mg of the aqueous solution, is applied per cm2 to a respective side of the fabric.

### Claim 19 (depends on 1)

Method according to claim 1, characterised in that the hydroactive constituents have carboxymethyl cellulose and/or cellulose ethyl sulphonate.

### Claim 20 (depends on 1)

Method according to claim 1, characterised in that the proportion of hydroactive constituents in the fabric is 50% or more by weight, in particular 75% or more by weight, more preferably about 80% by weight.

### Claim 21 (depends on 1)

Wound care product manufactured using a method according to claim 1, with a fabric having hydroactive constituents, in particular fibres, characterised in that at least some hydroactive constituents are provided with an antimicrobial means.

### Claim 22 (depends on 1)

Aqueous solution for the implementation of a method according to claim 1, with 0.1 to 9% by weight of PHMB, 0.5 to 15% by weight of EDTA disodium salt, 0.1 to 5% by weight of EHG and 0 to 2.5% by weight of Tween 20.
